AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Insights on Cancer Survivorship and Toxicities from Checkpoint Inhibitors
Patients receiving checkpoint inhibitors may experience toxicities that are evolving in how they are understood, with skin rash occurring early, followed by colitis and endocrine issues. Prompt treatment of these toxicities, even months or years after treatment, is essential as delays can lead to irreversible complications like endocrineopathies necessitating hormone replacement therapy.